TELEBPMET: Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological Determinants

Sponsor
Italian Institute of Telemedicine (Other)
Overall Status
Completed
CT.gov ID
NCT01541566
Collaborator
Bracco Corporate (Industry), Istituto Auxologico Italiano (Other)
254
12
37
21.2
0.6

Study Details

Study Description

Brief Summary

The purpose of this study is to assess whether, in patients at high cardiovascular risk (hypertension with metabolic syndrome), long-term (1-year) blood pressure control is most effective when based on home blood pressure telemonitoring and on the feedback to the patient by the doctor between visits, or when based only on blood pressure determination during quarterly office visits.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    254 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring
    Study Start Date :
    Nov 1, 2007
    Actual Primary Completion Date :
    Dec 1, 2010
    Actual Study Completion Date :
    Dec 1, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    Home blood pressure telemonitoring

    Patients regularly monitoring their blood pressure at home with an electronic validated upper arm device, transmitting blood pressure values at monthly intervals to the doctors office through the Internet.

    Conventional blood pressure measurement

    Blood pressure measured only in the doctor's office during quarterly visits, without regular home blood pressure monitoring.

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of subjects with average day-time ambulatory blood pressure <135/85 mmHg [6 months]

    2. Percentage of subjects with average day-time ambulatory blood pressure <135/85 mmHg [12 months]

    Secondary Outcome Measures

    1. Psychological determinats of therapeutic adherence [6 months]

    2. Percentage of subjects with office blood pressure <140/90 mmHg [6 months]

    3. Changes in home blood pressure [6 months]

    4. Number of additional medical visits [6 months]

    5. Direct costs of intervention [6 months]

    6. Number of antihypertensive drugs [6 months]

    7. Level of cardiovascular risk by ESC Heart Score and Framingham [6 months]

    8. Target organ damage and outcomes [6 months]

    9. Percentage of patients with metabolic syndrome [6 months]

    10. Psychological determinats of therapeutic adherence [12 months]

    11. Percentage of subjects with office blood pressure <140/90 mmHg [12 months]

    12. Changes in home blood pressure [12 months]

    13. Number of additional medical visits [12 months]

    14. Direct costs of intervention [12 months]

    15. Number of antihypertensive drugs [12 months]

    16. Level of cardiovascular risk by ESC Heart Score and Framingham [12 months]

    17. Target organ damage and outcomes [12 months]

    18. Percentage of patients with metabolic syndrome [12 months]

    19. Percentage of subjects with home blood pressure <135/85 mmHg [6 months]

    20. Percentage of subjects with home blood pressure <135/85 mmHg [12 months]

    21. Changes in 24h blood pressure [6 months]

    22. Changes in 24h blood pressure [12 months]

    23. Changes in office blood pressure [6 months]

    24. Changes in office blood pressure [12 months]

    25. Adherence to treatment [6 months]

    26. Adherence to treatment [12 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 74 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Treated or untreated uncontrolled essential arterial hypertension (office systolic blood pressure >140 or diastolic >90 mmHg + day-time systolic blood pressure >135 or day-time diastolic blood pressure >85 mmHg)

    • Metabolic syndrome (ATP III criteria)

    Exclusion Criteria:
    • Secondary arterial hypertension

    • Severe liver or kidney disease

    • Immunological disease

    • Cardiac arrhythmias

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fondazione Maugeri Lumezzane Brescia Italy 25066
    2 Ospedale San Felice a Cancello San Felice a Cancello Caserta Italy 81027
    3 Ospedale di Broni Broni Pavia Italy 27043
    4 Policlinico Universitario Bari Italy 70124
    5 Spedali Civili Brescia Italy 25123
    6 Istituto Auxologico Italiano Milano Italy 20149
    7 Policlinico Universitario Padova Italy 35128
    8 Fondazione Maugeri Pavia Italy 27100
    9 Ospedale Santa Chiara Pisa Italy 56100
    10 Ospedale Fatebenefratelli Roma Italy 00186
    11 Casa di Cura Tortorella Salerno Italy 84122
    12 Ospedale di Circolo Varese Italy 21100

    Sponsors and Collaborators

    • Italian Institute of Telemedicine
    • Bracco Corporate
    • Istituto Auxologico Italiano

    Investigators

    • Principal Investigator: Gianfranco Parati, MD, Istituto Auxologico Italiano

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Italian Institute of Telemedicine
    ClinicalTrials.gov Identifier:
    NCT01541566
    Other Study ID Numbers:
    • TELEBPMET
    First Posted:
    Mar 1, 2012
    Last Update Posted:
    Feb 26, 2016
    Last Verified:
    Feb 1, 2016

    Study Results

    No Results Posted as of Feb 26, 2016